GSK

10 Risky (But Rewarding) Small-Cap Stocks to Buy Now

By James Brumley, InvestorPlace Feature Writer
These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward.

9 Blue-Chip Stocks That Will Lose You Money

By James Brumley, InvestorPlace Feature Writer
Think all blue-chip stocks are safe buys at any time? Think again. These companies may be about to stumble, if they haven't already.

3 Life Sciences Stocks to Invest In

By Chris Lau, InvestorPlace Contributor
Generic drug companies are on discount for investors who want to buy life sciences stocks. Why, and when will this sector recover?

3 Biopharma Stocks to Buy for Their Robust Dividend Yields

By Tezcan Gecgil, InvestorPlace Contributor
These three biopharma stocks to buy should help investors maintain strength amid any potential chaos in 2019.

GlaxoSmithKline (GSK) Stock Pops on Pfizer Joint Venture

By William White, InvestorPlace Writer
GlaxoSmithKline (GSK) stock is up today on news of a new joint venture with Pfizer (PFE) for a consumer healthcare business.

3 Big Stock Charts for Tuesday: Morgan Stanley, Ross Stores and Dominion Energy

By James Brumley, InvestorPlace Feature Writer
The stock charts of ROST, D and MS are shaping up as the top trading prospects as December's action gets going.

TSRO, GSK: Tesaro Stock Skyrockets on GlaxoSmithKline Deal

By William White, InvestorPlace Writer
Tesaro stock was flying high on Monday with news that GlaxoSmithKline (GSK) is planning to acquire it in a deal worth $5.10 billion.

6 of the Best Dividend Stocks Outside the U.S.

By Vince Martin, InvestorPlace Contributor
If you're looking for the best dividend stocks with high yields and solid growth prospects, don't limit yourself -- look overseas.

7 Healthcare Stocks That Are Coming to Life

By Anthony Mirhaydari, InvestorPlace Market Strategist
These seven healthcare stocks are coming to life Monday. Here's how to play these companies without getting burnt.

GlaxoSmithKline Is More Than Just a 5% Dividend Income Play

By Chris Lau, InvestorPlace Contributor
GlaxoSmithKline pays shareholders a solid dividend yet the company is not just for income investors. In the next few years, growth in the consumer unit will lead to strong cash flow, raising the chances of dividend hikes for GSK stock.

7 Small-Cap Stocks to Consider for the Second Half of 2018

By James Brumley, InvestorPlace Feature Writer
Small-cap stocks have been on a tear of late. Take the hint, and start your search with these seven top prospects.

The 3 Safest Dividend Stocks for International Exposure

By Lawrence Meyers, InvestorPlace Contributor
International dividend stocks should make up a hefty portion of your portfolio, as you need them to smooth out the sort of stateside volatility we're experiencing right now.

4 Drug and Biotech Stocks Awaiting FDA Decisions in July

By
In the first six months of the year, the FDA grants approval to 17 new treatments. Compare Brokers....

3 Stocks Raising Hopes in Troubled Large-Cap Pharma Industry

By
Though the large-cap pharma industry is struggling currently, there are a few stocks that are performing well. Compare Brokers....

FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs

By Karl Utermohlen, InvestorPlace Writer
The Food and Drug Administration (FDA) announced a list of drug makers that have tried to block generic drugs in its new shame list. Here they are.

GlaxoSmithKline plc Shares Sink on Q1 Earnings Miss

By William White, InvestorPlace Writer
GlaxoSmithKline (GSK) stock was down on Wednesday following the release of an earnings report that misses estimates for the first quarter of 2018.

7 Dividend Stocks That May Be Hurting Your Retirement

By Brian Bollinger, Simply Safe Dividends
Often there are signs leading up to dividend stocks cutting their payouts. If you own any of these 7 you'd be better off moving your money elsewhere.

3 Emerging Technologies Set to Transform the Pharma World

By
Here we discuss three emerging technologies, which the pharma/biotech industry has started adopting, albeit slowly. These are poised to transform the sector by....

GlaxoSmithKline plc (ADR) Stock Jumps on $13 Billion Novartis Deal

By William White, InvestorPlace Writer
GlaxoSmithKline (GSK) stock was up today on news of a $13 billion deal with Novartis (NVS) that it set to close in Summer 2018.
Load More